Shijun Lv
Overview
Explore the profile of Shijun Lv including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
716
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen X, Song F, Xiao P, Yao Y, Li D, Fang Y, et al.
BMC Cancer
. 2025 Mar;
25(1):402.
PMID: 40045286
Background: Head and neck squamous cell carcinoma (HNSCC) is among the most aggressive malignancies, underscoring the need for early diagnosis to improve patient outcomes. Tumor-derived exosomes, which can be non-invasively...
2.
Miao Y, Yin Q, Ping L, Sheng H, Chang J, Li W, et al.
J Cancer Res Ther
. 2023 Dec;
19(6):1646-1653.
PMID: 38156933
Background: Ferroptosis is a novel subtype of programmed cell death caused by iron-dependent lipid peroxidation and excessive reactive oxygen species (ROS) production. Small-molecule ferroptotic drugs have the probability of selectively...
3.
Li W, Liu C, Zhao C, Zhai L, Lv S
Int J Oncol
. 2021 Jan;
58(3):419-420.
PMID: 33432370
Following the publication of the above paper, an interested reader drew to the authors' attention that, in Fig. 2D, the si‑ITGB3/E‑cadherin image appeared to show an overlap with the Scr/MDA231+CCL18/N‑cadherin...
4.
Gai C, Liu C, Wu X, Yu M, Zheng J, Zhang W, et al.
Cell Death Dis
. 2020 Sep;
11(9):751.
PMID: 32929075
Although ferroptosis has been recognized as a novel antitumoral treatment, high expression of nuclear factor erythroid 2-related factor 2 (NRF2) has been reported to be an antioxidant transcript factor that...
5.
Lu C, Ren C, Yang T, Sun Y, Qiao P, Wang D, et al.
Mol Cancer Res
. 2020 Feb;
18(5):787-796.
PMID: 32041737
Breast cancer is a leading cause of death in women worldwide, but the underlying mechanisms of breast tumorigenesis remain unclear. Fructose-1, 6-bisphosphatase 1 (FBP1), a rate-limiting enzyme in gluconeogenesis, was...
6.
Gai C, Yu M, Li Z, Wang Y, Ding D, Zheng J, et al.
J Cell Physiol
. 2019 Sep;
235(4):3329-3339.
PMID: 31541463
Growing evidence confirms that ferroptosis plays an important role in tumor growth inhibition. However, some non-small-cell lung cancer (NSCLC) cell lines are less sensitive to erastin-induced ferroptotic cell death. Elucidating...
7.
Li H, Mou Q, Li P, Yang Z, Wang Z, Niu J, et al.
J Cancer
. 2019 Sep;
10(19):4695-4706.
PMID: 31528235
Epithelial-mesenchymal transition (EMT) is one of important steps that lead to cancer metastasis. Interleukin-22 (IL-22) is a T helper 17 (Th17) cells-secreted cytokine, it can promote invasion and metastasis of...
8.
Yang T, Ren C, Qiao P, Han X, Wang L, Lv S, et al.
Oncogene
. 2019 Sep;
39(3):720-721.
PMID: 31511646
A correction to this paper has been published and can be accessed via a link at the top of the paper.
9.
Yu M, Gai C, Li Z, Ding D, Zheng J, Zhang W, et al.
Cancer Sci
. 2019 Aug;
110(10):3173-3182.
PMID: 31464035
Ferroptosis is an iron-dependent, lipid peroxide-driven cell death caused by inhibition of the cystine/glutamate transporter, which is of importance for the survival of triple-negative breast cancer (TNBC) cells. Erastin is...
10.
Yang T, Ren C, Lu C, Qiao P, Han X, Wang L, et al.
Cancer Res
. 2019 Aug;
79(20):5233-5244.
PMID: 31409638
Heat shock transcription factor 1 (HSF1) is the master regulator of the proteotoxic stress response, which plays a key role in breast cancer tumorigenesis. However, the mechanisms underlying regulation of...